We are live on ! Find out more
JC

JBF Capital Portfolio holdings

AUM $676M
1-Year Est. Return 24.74%
This Fund
S&P 500
This Quarter Est. Return
+2.55%
1 Year Est. Return
+24.74%
3 Year Est. Return
+92.87%
5 Year Est. Return
+111.85%
10 Year Est. Return
+399%
AUM
$693M
AUM Growth
-$12.8M
Cap. Flow
-$19.2M
Cap. Flow %
-2.77%
Top 10 Hldgs %
85.19%
Holding
97
New
19
Increased
10
Reduced
11
Closed
19

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$16.8M
2
META icon
Meta Platforms (Facebook)
META
+$6.68M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$6.14M
4
DELL icon
Dell
DELL
+$4.68M
5
CRWD icon
CrowdStrike
CRWD
+$4.68M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.45%
2 Technology 14.98%
3 Communication Services 7.49%
4 Financials 2.69%
5 Healthcare 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TKC icon
76
Turkcell
TKC
$4.98B
$82K 0.01%
15,000
CRNT icon
77
Ceragon Networks
CRNT
$197M
$76.6K 0.01%
36,458
FPH icon
78
Five Point Holdings
FPH
$380M
$55.9K 0.01%
+10,000
New +$59.1K
CRWD icon
79
CrowdStrike
CRWD
$207B
-38,148
Closed -$4.68M
DELL icon
80
Dell
DELL
$256B
-33,000
Closed -$4.68M
ETNB
81
DELISTED
89bio
ETNB
-50,000
Closed -$735K
FSLR icon
82
First Solar
FSLR
$22.8B
-4,551
Closed -$1M
GLUE icon
83
Monte Rosa Therapeutics
GLUE
$2.07B
-148,566
Closed -$1.1M
GPRK icon
84
GeoPark
GPRK
$628M
-10,000
Closed -$63.7K
GTLB icon
85
GitLab
GTLB
$5.53B
-21,200
Closed -$956K
HOOK
86
DELISTED
HOOKIPA Pharma
HOOK
-347,000
Closed -$321K
LAB icon
87
Standard BioTools
LAB
$350M
-770,654
Closed -$1M
LVTX
88
DELISTED
LAVA Therapeutics
LVTX
-23,911
Closed -$37.3K
LWAY icon
89
Lifeway Foods
LWAY
$488M
-27,500
Closed -$763K
NOW icon
90
ServiceNow
NOW
$106B
-16,020
Closed -$2.95M
PRME icon
91
Prime Medicine
PRME
$565M
-188,900
Closed -$1.05M
PSNL icon
92
Personalis
PSNL
$1.61B
-166,104
Closed -$1.08M
SCPH
93
DELISTED
scPharmaceuticals
SCPH
-135,000
Closed -$765K
THRD
94
DELISTED
Third Harmonic Bio
THRD
-250,000
Closed -$7.5K
THTX
95
DELISTED
Theratechnologies
THTX
-850,655
Closed -$2.88M
TWST icon
96
Twist Bioscience
TWST
$5.84B
-37,100
Closed -$1.04M
WFC icon
97
Wells Fargo
WFC
$265B
-200,000
Closed -$16.8M

Similar funds

JBF Capital's Q4 2025 Portfolio in Review

As of Q4 2025, JBF Capital held 97 positions worth $693M, down 1.8% from $706M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

JBF Capital's Q4 2025 filing shows 19 new, 10 increased, 11 reduced and 19 closed positions. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 50,000 shares worth $9.58M. The largest sale was Wells Fargo, an estimated $16.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 15% a quarter earlier, followed by Technology and Communication Services.

  • JBF Capital's largest Q4 2025 buy was Invesco S&P 500 Equal Weight ETF: 50,000 shares worth $9.58M.
  • JBF Capital added most to State Street SPDR S&P Biotech ETF in Q4 2025, an estimated $10.3M increase.
  • JBF Capital's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $6.68M.
  • JBF Capital fully exited Wells Fargo in Q4 2025, selling an estimated $16.8M.
  • JBF Capital's ten largest holdings make up 85% of its $693M portfolio in Q4 2025.
  • JBF Capital opened 19 new positions and closed 19 in Q4 2025.
  • JBF Capital's portfolio value fell 1.8% quarter-over-quarter to $693M.

Based on JBF Capital's 13F filing for Q4 2025, filed 12 Feb 2026.